These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11820197)

  • 21. Blood groups differ on donor deferral.
    Mitka M
    JAMA; 2001 Apr; 285(13):1694-5. PubMed ID: 11277807
    [No Abstract]   [Full Text] [Related]  

  • 22. Implementing a validation program in a cord blood bank.
    O'Neil B
    J Hematother; 1996 Apr; 5(2):139-43. PubMed ID: 8723790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Requirements for testing human blood donors for evidence of infection due to communicable disease agents. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Jun; 66(112):31146-65. PubMed ID: 11725786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FDA NPRM would standardize blood labeling to permit inventory automation.
    McNeal BM
    Health Law Vigil; 1980 Dec; 3(24):6-7. PubMed ID: 10248995
    [No Abstract]   [Full Text] [Related]  

  • 25. Red Cross reorganizes to ensure blood safety.
    Wagner L
    Mod Healthc; 1991 Nov; 21(47):15. PubMed ID: 10114994
    [No Abstract]   [Full Text] [Related]  

  • 26. AABB and FDA: a shared history of patient safety.
    Lipton KS; Otter J
    Transfusion; 2010 Aug; 50(8):1643-6. PubMed ID: 20931688
    [No Abstract]   [Full Text] [Related]  

  • 27. Blood & politics.
    Titus K
    CAP Today; 1996 Mar; 10(3):20, 22-4. PubMed ID: 10160264
    [No Abstract]   [Full Text] [Related]  

  • 28. Exemption of certain transfusion services and clinical laboratories from registration: Food and Drug Administration. Final rule.
    Fed Regist; 1980 Dec; 45(251 Pt 1):85727-30. PubMed ID: 10298064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A bloody mess. New safeguards will cut supplies of a lifesaving resource.
    Sobel RK
    US News World Rep; 2001 Sep; 131(8):36-9. PubMed ID: 11550392
    [No Abstract]   [Full Text] [Related]  

  • 30. AIDS and the blood supply: an analysis of law, regulation, and public policy.
    Salbu SR
    Wash Univ Law Q; 1996; 74(4):913-80. PubMed ID: 16273697
    [No Abstract]   [Full Text] [Related]  

  • 31. Product liability. Fault lines.
    Wilder G
    Health Serv J; 2001 Jun; 111(5760):suppl 12. PubMed ID: 11436764
    [No Abstract]   [Full Text] [Related]  

  • 32. Informing a recipient of blood from a donor who developed Creutzfeldt-Jakob disease: the characteristics of information that warrant its disclosure.
    Steinberg D
    J Clin Ethics; 2001; 12(2):134-40. PubMed ID: 11642064
    [No Abstract]   [Full Text] [Related]  

  • 33. Gen-Probe, Chiron and US Red Cross to investigate new technology to provide an extra layer of safety to the blood supply.
    Front Med Biol Eng; 1999; 9(1):96-8. PubMed ID: 10354914
    [No Abstract]   [Full Text] [Related]  

  • 34. Food safety inspections: a call for rational reorganization.
    DeWaal CS
    Food Drug Law J; 1999; 54(3):453-8. PubMed ID: 11797708
    [No Abstract]   [Full Text] [Related]  

  • 35. Revisions to the requirements applicable to blood, blood components, and source plasma; confirmation in part and technical amendment. Food and Drug Administration, HHS. Direct final rule; confirmation in part and technical amendment.
    Fed Regist; 2001 Jan; 66(7):1834-7. PubMed ID: 11503754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The FDA and product recalls.
    Meadows M
    FDA Consum; 2006; 40(3):30-5. PubMed ID: 16906665
    [No Abstract]   [Full Text] [Related]  

  • 37. Blood bank held to reasonably prudent standard of care, not industry standard.
    J Health Hosp Law; 1991 Oct; 24(10):325-6. PubMed ID: 10183534
    [No Abstract]   [Full Text] [Related]  

  • 38. Extended platelet storage makes a welcome difference.
    Townsend L
    MLO Med Lab Obs; 2007 Jun; 39(6):40-1. PubMed ID: 17691706
    [No Abstract]   [Full Text] [Related]  

  • 39. Knowledge of food and drug administration reportable deviations.
    Lam R; Bryant BJ
    Transfusion; 2011 Jul; 51(7 Pt 2):1619-23. PubMed ID: 21736583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controversies in transfusion medicine. Blood banks should use good manufacturing practices and the pharmaceutical manufacturing approach [corrected].
    Miller WV
    Transfusion; 1993 May; 33(5):435-8. PubMed ID: 8488549
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.